MedicarePartD.guide

A non-government resource built from CMS public data

Fasenra on HealthSpring Assurance Rx (S5617-118)

benralizumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 0.5 per 28 days.

$516.45
Patient pays / month, after deductible
$977.70
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

FASENRA 10 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $2,065.80 for a month. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
FASENRA 30 mg/mL Injection, Solution5$1,275.72PA · 1 per 28 days
FASENRA 10 mg/.5mL Injection, Solution5$516.45PA · 0.5 per 28 days
FASENRA 30 mg/mL Injection, Solution5$1,277.01PA · 1 per 28 days

Other Asthma and COPD biologics on this plan

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-118